Plunkett Research Online: Insmed Inc

INSMED INC (INSM:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Insmed, Inc. is a biologics manufacturing and development stage company with expertise in recombinant protein drug development. The firm’s lead product candidate is ARIKACE, a differentiated, inhaled antibiotic supported by positive Phase II results for treating serious lung infections due to susce.....



Insmed Inc
Ticker: INSM
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 908-977-9900
Fax:
Address: 10 Finderne Avenue
Building 10
Bridgewater, NJ 08807 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Metabolic & Endocrine Diseases
Drugs-Cancer
Drugs-Amyotrophic Lateral Sclerosis
ContactsDescription
William LewisCEO/Director/President
Paolo TombesiCFO
See More
Insmed, Inc. is a biologics manufacturing and development stage company with expertise in recombinant protein drug development. The firm’s lead product candidate is ARIKACE, a differentiated, inhaled antibiotic supported by positive Phase II results for treating serious lung infections due to susce.....See More See More

Auditor: ERNST & YOUNG LLP
Legal Advisor: Greenberg Traurig, LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ARIKAYCE
eFlow Nebulizer System
INS1009
INS1007
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: